Skip to main content

About Crohn’s & Colitis Hub

A diagnosis of inflammatory bowel disease (IBD) can be an emotional time, especially with the lack of information about the condition among the general community. We have created a safe place; a credible source of information, your go-to place to turn to if you are looking for answers, read inspirational stories from people in the same situation as yours, explore ongoing research in the field, and much more. Crohn’s & Colitis Hub provides a comprehensive range of information and support to help people find the right information or service for their individual needs.

Nearly 85,000 Australians are living with inflammatory bowel disease, the collective term used for Crohn’s disease and ulcerative colitis, a gastrointestinal condition that affects any part of the gut, though the most common area affected is the end of the ileum or the colon.

Symptoms vary from person to person, and range from mild to severe and can change over time. Most common symptoms include diarrhoea, abdomen pain, loss of appetite, anaemia, joint pain and mouth ulcers.

Presently, there is no cure for IBD, and the exact cause is still unknown.To manage the condition, it is essential to develop know-how on the potential impact of living with the condition, managing IBD and information on overcoming everyday challenges associated with the condition.

Crohn’s & Colitis Hub’s resources will include news, articles, features and videos curated from all across the web, including medical journals, functioning as a one-stop website focusing on IBD and related issues.

For additional information on inflammatory bowel disease resources, contact Crohn’s & Colitis Australia at 1800 138 029.

The latest news and Research

News

Gutsy effort to produce comprehensive study of intestinal gases

Posted: September 18 2019

A source of embarrassment to some, or pure comedy to others, flatulence and the gases of the intestines are increasingly seen as playing an important role in our digestive health. A paper led by UNSW Sydney and published in Nature Reviews Gastroenterology & Hepatology has examined all available literature on gastrointestinal gases, their interactions with the microbiome […]

Read more

News

Putting an end to inflammation

Posted: September 18 2019

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has succeeded in securing research funding in one of the toughest European selection processes. Over the next five years, the European Research Council (ERC) will support his outstanding research project with an ERC Starting Grant of 1.5 million euros. Dr. Andreas Ramming from the Department of Medicine […]

Read more

Research

Scientists discover promising new lead in Crohn’s disease

QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition.

Crohn’s disease – also known as inflammatory bowel disease – is incurable and affects about 35,000 people in Australia. QIMR Berghofer scientists found the protein PD-L2 was overactive in people with Crohn’s disease. The study was led by the head of the Molecular Immunology group, Dr Michelle Wykes, and Dr Graham Radford-Smith, who leads the […]

Read more

Personal Story

Student with stoma accused of taking drugs

Posted: September 11 2019

Amber Davies, 21, from Builth Wells, has a stoma after being diagnosed with ulcerative colitis aged 13. While on a night out in Birmingham, she was “grabbed” by a bouncer after coming out of the disabled toilet. Wetherspoons said staff apologised for the “confusing situation”. Amber posted an open letter on her Instagram account detailing her experience, saying the […]

Read more

Research

Diet-induced remission of Crohn’s disease associated with altered microbial community structure

Researchers from the University of Pennsylvania looked at the association of diet, gut microbiome and IBD.

Background The microbiome has been implicated in the initiation and persistence of inflammatory bowel disease. Despite the fact that diet is one of the most potent modulators of microbiome composition and function and that dietary intervention is the first-line therapy for treating pediatric Crohn’s disease, the relationships between diet-induced remission, enteropathy, and microbiome are poorly […]

Read more

News

Serotonin and anti-depressants can have a major effect on the gut’s microbiota

Posted: September 11 2019

Serotonin — a neurotransmitter, or chemical messenger that sends messages among cells — serves many functions in the human body, including playing a role in emotions and happiness. An estimated 90% of the body’s serotonin is produced in the gut, where it influences gut immunity. The team — led by senior author Elaine Hsiao and […]

Read more